Related Experiment Video

Updated: Dec 7, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

549

Examining the Potential Relationship Between Multidisciplinary Team Meetings and Patient Survival in Pediatric

Suzan Dijkstra1, Kathelijne C J M Kraal, Veerle J Ruijters

  • 1Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Journal of Pediatric Hematology/Oncology
|October 1, 2020
PubMed

Insights

Multidisciplinary team meetings (MTMs) in pediatric oncology may improve survival, but evidence is limited. Further research is needed to confirm the survival benefits of MTMs for childhood cancer patients.

Area of Science:

  • Pediatric Oncology
  • Clinical Research Methodology
  • Health Services Research

Background:

  • Multidisciplinary team meetings (MTMs) are standard in pediatric oncology, believed to enhance communication and patient care.
  • While MTMs' survival impact is studied in adults, its effect on pediatric cancer patients remains unclear.

Purpose of the Study:

  • To systematically review the impact of MTMs on survival outcomes in pediatric oncology.

Main Methods:

  • Searched MEDLINE/PubMed, EMBASE, and Cochrane Library databases up to January 2020.
  • Included 5 studies (1 prospective, 4 retrospective cohort) after screening 325 records.
  • Analyzed studies comparing survival in MTM-discussed versus non-MTM patients.

Main Results:

  • Three of the 5 included studies found a statistically significant association between MTMs and improved overall or event-free survival.
  • Study quality was limited by design, and significant clinical and methodological heterogeneity was noted.

Conclusions:

  • A definitive causal link between MTMs and improved survival in pediatric cancer cannot be established due to limited, heterogeneous studies.
  • Further high-quality research is essential to validate MTMs' survival benefits and guide resource allocation for optimal childhood cancer care.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
557
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
451
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
443
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
107